Dominic P D'Agostino Selected Research

Ketosis

11/2021	Adenosine Receptors Modulate the Exogenous Ketogenic Supplement-Evoked Alleviating Effect on Lipopolysaccharide-Generated Increase in Absence Epileptic Activity in WAG/Rij Rats.
1/2021	Ketone Supplementation: Meeting the Needs of the Brain in an Energy Crisis.
1/2021	Case Report: Ketogenic Diet Is Associated With Improvements in Chronic Obstructive Pulmonary Disease.
8/2020	Exogenous Ketone Supplements Improved Motor Performance in Preclinical Rodent Models.
3/2020	Effects of an Exogenous Ketone Supplement on Five-Kilometer Running Performance.
1/2020	Evaluation of the safety and tolerability of a nutritional Formulation in patients with ANgelman Syndrome (FANS): study protocol for a randomized controlled trial.
1/2020	Inhibition of adenosine A1 receptors abolished the nutritional ketosis-evoked delay in the onset of isoflurane-induced anesthesia in Wistar Albino Glaxo Rijswijk rats.
1/2019	Ketone Administration for Seizure Disorders: History and Rationale for Ketone Esters and Metabolic Alternatives.
1/2019	Therapeutic Potential of Exogenous Ketone Supplement Induced Ketosis in the Treatment of Psychiatric Disorders: Review of Current Literature.
1/2019	Exogenous Ketone Supplementation Decreased the Lipopolysaccharide-Induced Increase in Absence Epileptic Activity in Wistar Albino Glaxo Rijswijk Rats.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Dominic P D'Agostino Research Topics

Disease

17	Ketosis 11/2021 - 05/2013
8	Body Weight (Weight, Body) 11/2021 - 01/2014
8	Neoplasms (Cancer) 01/2020 - 01/2013
6	Epilepsy (Aura) 01/2021 - 01/2017
4	Inflammation (Inflammations) 01/2020 - 01/2015
3	Absence Epilepsy (Childhood Absence Epilepsy) 01/2021 - 01/2019
3	Seizures (Absence Seizure) 01/2021 - 05/2013
3	Drug Resistant Epilepsy 01/2019 - 05/2013
2	Angelman Syndrome (Syndrome, Angelman) 01/2020 - 12/2016
1	Alzheimer Disease (Alzheimer's Disease) 01/2021
1	Hypoventilation 01/2021
1	Nervous System Diseases (Neurological Disorders) 01/2021
1	Hyperoxia 01/2021
1	Chronic Obstructive Pulmonary Disease (COPD) 01/2021
1	Cognitive Dysfunction 01/2021
1	Glut1 Deficiency Syndrome 08/2020
1	Hypoalbuminemia 01/2020
1	Anemia 01/2020
1	Unconsciousness (Loss of Consciousness) 01/2020
1	Neoplasm Metastasis (Metastasis) 01/2020
1	Atrophy 01/2020
1	Anorexia 01/2020
1	Migraine Disorders (Migraine) 04/2019
1	Obesity 01/2019
1	Mental Disorders (Mental Disorder) 01/2019
1	Melanoma (Melanoma, Malignant) 07/2017
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 07/2017
1	Leukemia 07/2017
1	Hyperlipidemias (Hyperlipidemia) 07/2017
1	Chronic Disease (Chronic Diseases) 07/2017
1	Glioblastoma (Glioblastoma Multiforme) 01/2017
1	Aneuploidy (Aneuploid) 02/2016
1	Brain Neoplasms (Brain Tumor) 01/2015
1	Metabolic Diseases (Metabolic Disease) 03/2014
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2014
1	Disease Progression 01/2014
1	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 01/2014

Drug/Important Bio-Agent (IBA)

23	KetonesIBA 11/2021 - 01/2013
9	EstersIBA 11/2021 - 05/2013
8	Blood Glucose (Blood Sugar)IBA 11/2021 - 01/2013
7	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 01/2013
7	Ketone BodiesIBA 01/2020 - 03/2014
6	3-Hydroxybutyric Acid (beta-Hydroxybutyric Acid)IBA 11/2021 - 01/2014
6	SaltsIBA 11/2021 - 01/2019
5	acetoacetic acid (acetoacetate)IBA 01/2021 - 05/2013
5	CarbohydratesIBA 01/2021 - 01/2013
4	Oxygen (Dioxygen)IBA 01/2021 - 01/2013
3	Triglycerides (Triacylglycerol)IBA 01/2021 - 03/2020
3	Glutamine (L-Glutamine)FDA Link 01/2017 - 03/2014
2	LipopolysaccharidesIBA 11/2021 - 01/2019
2	Pharmaceutical PreparationsIBA 01/2020 - 01/2017
2	Adenosine A1 ReceptorIBA 01/2020 - 01/2017
2	Isoflurane FDA LinkGeneric 01/2020 - 01/2018
2	AntioxidantsIBA 04/2019 - 09/2017
2	Imatinib Mesylate (Gleevec)FDA Link 07/2017 - 02/2016
1	pyrimidineIBA 11/2021
1	5- amino- 7- (2- phenylethyl)- 2- (2- furyl)pyrazolo(4,3- e)- 1,2,4- triazolo(1,5- c)pyrimidineIBA 11/2021
1	Adenosine (Adenocard)FDA LinkGeneric 11/2021
1	Purinergic P1 Receptors (Adenosine Receptor)IBA 11/2021
1	1,3-dipropyl-8-cyclopentylxanthineIBA 11/2021
1	UridineIBA 01/2021
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 01/2021
1	dihydroethidiumIBA 01/2021
1	Carbon DioxideIBA 01/2021
1	Coloring Agents (Dyes)IBA 01/2021
1	Superoxides (Superoxide)IBA 01/2021
1	Interleukin-6 (Interleukin 6)IBA 01/2021
1	CytokinesIBA 01/2021
1	Interleukin-8 (Interleukin 8)IBA 01/2021
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2021
1	Insulin (Novolin)FDA Link 01/2020
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2020
1	1,3-butylene glycolIBA 01/2020
1	NF-kappa B (NF-kB)IBA 01/2020
1	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2020
1	Insulin-Like PeptidesIBA 01/2020
1	UbiquitinIBA 01/2020
1	Proteins (Proteins, Gene)FDA Link 01/2020
1	Dietary Carbohydrates (Carbohydrate, Dietary)IBA 04/2019
1	Therapeutic UsesIBA 01/2019
1	Atorvastatin (Lipitor)FDA Link 07/2017
1	BiguanidesIBA 07/2017
1	Phenformin (Fenformin)IBA 07/2017
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 07/2017
1	Pyruvic Acid (Pyruvate)IBA 01/2017
1	Metformin (Glucophage)FDA LinkGeneric 01/2017
1	Sugar PhosphatesIBA 02/2016
1	DeuteriumIBA 02/2016
1	Drinking WaterIBA 02/2016
1	Bevacizumab (Avastin)FDA Link 02/2016
1	DNA (Deoxyribonucleic Acid)IBA 02/2016
1	Anti-Anxiety Agents (Anxiolytics)IBA 01/2016
1	Lactic Acid (Lactate)FDA LinkGeneric 01/2016
1	Glutamic Acid (Glutamate)FDA Link 01/2014

Therapy/Procedure

14	Ketogenic Diet 01/2021 - 01/2013
6	Therapeutics 04/2019 - 01/2013
2	Anesthesia 01/2020 - 01/2018
2	Diet Therapy (Therapy, Diet) 01/2020 - 01/2016
2	Oral Administration 01/2016 - 05/2013
1	Aftercare (After-Treatment) 01/2018